» Articles » PMID: 38726652

Primary Human Papillomavirus Test Uptake and Cervical Cancer Screening Trends in the Midwest, United States

Overview
Publisher Sage Publications
Specialty Health Services
Date 2024 May 10
PMID 38726652
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction/objectives: Despite U.S. Preventive Services Task Force and American Cancer Society endorsement of primary HPV screening, limited published data shows low uptake.

Primary Aim: Assess cervical cancer screening rates over time, particularly primary HPV test uptake, among patients in a midwestern practice.

Secondary Aim: Evaluate associations between sociodemographics and screening adherence.

Methods: Cross-sectional study. Qualifying subjects and type of screening test used were identified by applying ICD-9, ICD-10, lab test, and CPT codes to the Unified Data Platform. Sociodemographics were found through the electronic health record.

Results: Primary HPV uptake represented <1% of annual screening from 1/2017 to 1/2022. On 1/1/2022, only 55% of 21 to 29 year old and 63% of 30 to 65 year old were up to date with screening among the studied population. For 21 to 29 year old, compared with White women, Black women were 28% less likely to be screened [RR = 0.72 (0.66-0.79)]. Compared with never-smokers, current smokers were 9% less likely to be screened [RR = 0.91 (0.87-0.96)], past smokers were 14% more likely [RR = 1.14 (1.09-1.2)]. Among 30 to 65 year old, compared with White women, Black women were 14% less likely to be screened [RR = 0.86 (0.81-0.9)]. Compared with never-smokers, current smokers were 21% less likely to be screened [RR = 0.79 (0.77-0.81)], past smokers were 6% less likely [RR = 0.94 (0.92-0.95)]. Jointly considering race, ethnicity, smoking status, Charlson score, and rurality, findings were similar for 21 to 29 year old; Black women were screened less than White women [RR = 0.73 (0.67-0.79)]; current smokers [RR = 0.9 (0.85-0.94)] and past smokers [RR = 1.12 (1.06-1.17)] were screened less than never smokers. For 30 to 65 year old, Black women were screened less than White women [RR = 0.83 (0.79-0.88)]; current smokers [RR = 0.8 (0.78-0.81)] and past smokers [RR = 0.95 (0.93-0.96)] were screened less than never smokers.

Conclusions: Screening rates remained below the Healthy People 2030 goal of 79.2% over time, particularly for younger Black women and current smokers, with minimal use of primary HPV screening.

References
1.
Nelson W, Moser R, Gaffey A, Waldron W . Adherence to cervical cancer screening guidelines for U.S. women aged 25-64: data from the 2005 Health Information National Trends Survey (HINTS). J Womens Health (Larchmt). 2009; 18(11):1759-68. PMC: 2864462. DOI: 10.1089/jwh.2009.1430. View

2.
Qin J, Shahangian S, Saraiya M, Holt H, Gagnon M, Sawaya G . Trends in the use of cervical cancer screening tests in a large medical claims database, United States, 2013-2019. Gynecol Oncol. 2021; 163(2):378-384. PMC: 8585712. DOI: 10.1016/j.ygyno.2021.08.023. View

3.
Peirson L, Fitzpatrick-Lewis D, Ciliska D, Warren R . Screening for cervical cancer: a systematic review and meta-analysis. Syst Rev. 2013; 2:35. PMC: 3681632. DOI: 10.1186/2046-4053-2-35. View

4.
Boone E, Lewis L, Karp M . Discontent and Confusion: Primary Care Providers' Opinions and Understanding of Current Cervical Cancer Screening Recommendations. J Womens Health (Larchmt). 2015; 25(3):255-62. DOI: 10.1089/jwh.2015.5326. View

5.
Perkins R, Guido R, Castle P, Chelmow D, Einstein M, Garcia F . 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. J Low Genit Tract Dis. 2020; 24(2):102-131. PMC: 7147428. DOI: 10.1097/LGT.0000000000000525. View